PUBLICATIONS · 12065559
Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2002 Jun 15
- First author
- Hensley ML
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Hensley ML
- type
- Author
- name
- Maki R
- type
- Author
- name
- Venkatraman E
- type
- Author
- name
- Geller G
- type
- Author
- name
- Lovegren M
- type
- Author
- name
- Aghajanian C
- type
- Author
- name
- Sabbatini P
- type
- Author
- name
- Tong W
- type
- Author
- name
- Barakat R
- type
- Author
- name
- Spriggs DR
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Hensley ML
- type
- Author
- name
- Maki R
- type
- Author
- name
- Venkatraman E
- type
- Author
- name
- Geller G
- type
- Author
- name
- Lovegren M
- type
- Author
- name
- Aghajanian C
- type
- Author
- name
- Sabbatini P
- type
- Author
- name
- Tong W
- type
- Author
- name
- Barakat R
- type
- Author
- name
- Spriggs DR
- type
- Author
- bibliography ids
- nci-bib-ac9376bd01ddb0255b130994
- book metadata
- content sha256
- 297a0c1dbdff168f594cf758b34ae6ff6792c8efb673d30b516152122d0e4f86
- document type
- citation
- dois
- 10.1200/JCO.2002.11.050
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:12065559
- immutable id
- pubmed:12065559@297a0c1dbdff168f594cf758b34ae6ff6792c8efb673d30b516152122d0e4f86
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- Source null
- issn print
- 0732-183X
- issue
- 12
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 2824-31
- volume
- 20
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 12065559
- provenance
- batch id
- ced7794d3512d3f45188
- provider
- NCBI PubMed ESummary
- record sha256
- da1ca3eb0ed5c99a84d0dce77aa40f0b6fd7f7fd3077e5cf48787d2579d71b14
- response sha256
- 782bfef1f051086807ee9551561575ae64b9ca1f941a87d5259ff83e5424435e
- retrieved at
- 2026-09-09T23:45:46.208577+00:00
- publication date
- display
- 2002 Jun 15
- precision
- day
- year
- 2002
- publication types
- Clinical Trial
- Journal Article
- Research Support, Non-U.S. Gov't
- Research Support, U.S. Gov't, P.H.S.
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial.
Preserved source evidence · Not medical advice
Triangle